DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event

DNA and Cell Biology

Volumn 34, Issue 11, 2015, Pages 652-660

  Huang, Chun Jie ^a   Wu, Di ^a   Khan, Faheem Ahmed ^a   Huo, Li Jun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; SUMO PROTEIN; CYSTEINE PROTEINASE; PEPTIDE HYDROLASE; SENP2 PROTEIN, HUMAN;

BIOGENESIS; GENE EXPRESSION REGULATION; MITOCHONDRIAL DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; RIBOSOME; SUMOYLATION; ANIMAL; CELL CYCLE; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; PROCEDURES;

ANIMALS; CELL CYCLE; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; PEPTIDE HYDROLASES; RIBOSOMES; SUMOYLATION;

EID: 84946722160     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2015.2933     Document Type: Review

References (93)

1. Anderson, C. A., and Blackstone, C. (2013). SUMO wrestling with Drp1 at mitochondria. EMBO J 32, 1496-1498.
2. Andreou, A. M., and Tavernarakis, N. (2010). Roles for SUMO modification during senescence. Adv Exp Med Biol 694, 160-171.
3. Andrews, W. J., Panova, T., Normand, C., Gadal, O., Tikhonova, I. G., and Panov, K. I. (2013). Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription. J Biol Chem 288, 4567-4582.
4. Aoki, I., Higuchi, M., and Gotoh, Y. (2013). NEDDylation controls the target specificity of E2F1 and apoptosis induction. Oncogene 22, 3954-3964.
5. Bailey, D., and O'Hare, P. (2004). Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J Biol Chem 279, 692-703.
6. Bawa-Khalfe, T., Cheng. J., Lin, S. H., Ittmann, M. M., and Yeh, E. T. (2010). SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms. J Biol Chem 285, 25859-25866.
7. Bettermann, K., Benesch, M., Weis, S., and Haybaeck, J. (2012). SUMOylation in carcinogenesis. Cancer Lett 316, 113-125.
8. Burger, K. (2013). Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism. Biol Chem 9, 1133-1143.
9. Castle, C. D., Cassimere, E. K., and Denicourt, C. (2011). LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis. Mol Biol Cell 23, 716-728.
10. Castle, C. D., Cassimere, E. K., Lee, J., and Denicourt, C. (2010). Las1L is a nucleolar protein required for cell proliferation and ribosome biogenesis. Mol Cell Biol 30, 4404-4414.
11. Chan, J. C., Hannan, K. M., Riddell, K., Ng, P. Y., Peckm, A., Lee, R. S., Hung, S., Astle, M. V., Bywater, M., and Wall, M. (2011). AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer. Sci Signal 4, ra56.
12. Chen, Y., Li, S., Li, Y. J., Su, Y., Wong, S., and Zaia, J. (2012). Inhibitors of desumoylation enzymes and methods for their use. http://www. google. com/patents/WO2012064887A1?cl= en Google Patents
13. Chiu, S. Y., Asai, N., Costantini, F., and Hsu, W. (2008). SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol 6, e310.
14. Choi, H. K., Choi, K. C., Yoo, J. Y., Song, M., Ko, S. J., Kim, C. H., Ahn, J. H., Chun, K. H., Yook, J. I., and Yoon, H. G. (2011). Reversible SUMOylation of TBL1-TBLR1 regulates beta-catenin-mediated Wnt signaling. Mol Cell 43, 203-216.
15. Chow, K. H., Elgort, S., Dasso, M., Powers, M. A., and Ullman, K. S. (2014). The SUMO proteases SENP1 and SENP2 play a critical role in nucleoporin homeostasis and nuclear pore complex function. Mol Biol Cell 25, 160-168.
16. Di Bacco, A., Ouyang, J., Lee, H. Y., Catic, A., Ploegh, H., and Gill, G. (2006). The SUMO-specific protease SENP5 is required for cell division. Mol Cell Biol 26, 4489-4498.
17. Dou, H., Huang, C., Singh, M., Carpenter, P. B., and Yeh, E. T. (2010). Regulation of DNA repair through deSUMOylation and SUMOylation of replication protein A complex. Mol Cell 13, 333-345.
18. Ehrentraut, S. F., Kominsky, D. J., Glover, L. E., Campbell, E. L., Kelly, C. J., Bowers, B. E., Bayless, A. J., and Colgan, S. P. (2013). Central role for endothelial human deneddylase-1/ SENP8 in fine-tuning the vascular inflammatory response. J Immunol 1, 392-400.
19. Era, S., Abe, T., Arakawa, H., Kobayashi, S., Szakal, B., Yoshikawa, Y., Motegi, A., Takeda, S., and Branzei, D. (2012). The SUMO protease SENP1 is required for cohesion maintenance and mitotic arrest following spindle poison treatment. Biochem Biophys Res Commun 28, 310-316.
20. Finkbeiner, E., Haindl, M., and Muller, S. (2011). The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex. EMBO J 30, 1067-1078.
21. Fromont-Racine, M., Senger, B., Saveanu, C., and Fasiolo, F. (2003). Ribosome assembly in eukaryotes. Gene 313, 17-42.
22. Golomb, L., Volarevic, S., and Oren, M. (2014). p53 and ribosome biogenesis stress: The essentials. FEBS Lett 16, 2571-2579.
23. Gonzalez-Prieto, R., Cuijpers, S. A., Kumar, R., Hendriks, I. A., and Vertegaal, A. C. (2015). c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4. Cell Cycle 14, 1859-1872.
24. Guo, C., Hildick, K. L., Luo, J., Dearden, L., Wilkinson, K. A., and Henley, J. M. (2013). SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia. EMBO J 32, 1514-1528.
25. Haindl, M., Harasim, T., Eick, D., and Muller, S. (2008). The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep 9, 273-279.
26. Han, Y., Huang, C., Sun, X., Xiang, B., Wang, M., Yeh, E. T., Chen, Y., Li, H., Shi, G., Cang, H., Sun, Y., Wang, J., Wang, W., Gao, F., and Johnson, E. S. (2004). Protein modification by SUMO. Annu Rev Biochem 73, 355-382.
27. Hay, R. T. (2005). SUMO: A history of modification. Mol Cell 18, 1-12.
28. Hay, R. T. (2007). SUMO-specific proteases: A twist in the tail. Trends Cell Biol 17, 370-376.
29. Heo, K. S., Chang, E., Le, N. T., Cushman, H., Yeh, E. T., Fujiwara, K., and Abe, J. (2013). De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis. Circ Res 112, 911-923.
30. Hickey, C. M., Wilson, N. R., and Hochstrasser, M. (2012). Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol 13, 755-766.
31. Huang, C., Han, Y., Wang, Y., Sun, X., Yan, S., Yeh, E. T., Chen, Y., Cang, H., Li, H., Shi, G., Cheng, J., Tang, X., and Yi, J. (2009). SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J 28, 2748-2762.
32. Hwang, E. J., Lee, J. M., Jeong, J., Park, J. H., Yang, Y., Lim, J. S., Kim, J. H., Baek, S. H., and Kim, K. I. (2009). SUMOylation of RORalpha potentiates transcriptional activation function. Biochem Biophys Res Commun 378, 513-517.
33. Jiang, M., Chiu, S. Y., and Hsu, W. (2011). SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Cell Death Differ 18, 1005-1015.
34. Johnson, A. W., Lund, E., and Dahlberg, J. (2002). Nuclear export of ribosomal subunits. Trends Biochem Sci 27, 580-585.
35. Kaikkonen, S., Makkonen, H., Rytinki, M., and Palvimo, J. J. (2010). SUMOylation can regulate the activity of ETS-like transcription factor 4. Biochim Biophys Acta 1799, 555-560.
36. Kang, X., Qi, Y., Zuo, Y., Wang, Q., Zou, Y., Schwartz, R. J., Cheng, J., and Yeh, E. T. (2010). SUMO-specific protease 2 is essential for suppression of polycomb group proteins mediated gene silencing during embryonic development. Mol Cell 38, 191-201.
37. Karbowski, M., and Youle, R. J. (2003). Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ 10, 870-880.
38. Kim, J. H., and Baek, S. H. (2009). Emerging roles of desumoylating enzymes. Biochim Biophys Acta 1792, 155-162.
39. Klein, U. R., Haindl, M., Nigg, E. A., and Muller, S. (2009). RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin. Mol Biol Cell 20, 410-418.
40. Knott, A. B., Perkins, G., Schwarzenbacher, R., and Bossy-Wetzel, E. (2008). Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9, 505-518.
41. Kolli, N., Mikolajczyk, J., Drag, M., Mukhopadhyay, D., Moffatt, N., Dasso, M., Salvesen, G., and Wilkinson, K. D. (2010). Distribution and paralogue specificity of mammalian deSUMOylating enzymes. Biochem J 430, 335-344.
42. Krumova, P., and Weishaupt, J. H. (2013). Sumoylation in neurodegenerative diseases. Cell Mol Life Sci 70, 2123-2138.
43. Lee, S., Park, Y. Y., Kim, S. H., Nguyen, O. T., Yoo, Y. S., Chan, G. K., Sun, X., and Cho, H. (2014). Human mitochondrial Fis1 links to cell cycle regulators at G2/M transition. Cell Mol Life Sci 71, 711-725.
44. Lindberg, M. J., Popko-Scibor, A. E., Hansson, M. L., and Wallberg, A. E. (2010). SUMO modification regulates the transcriptional activity of MAML1. FASEB J 24, 2396-2404.
45. Liu, X., Chen, W., Wang, Q., Li, L., and Wang, C. (2013). Negative regulation of TLR inflammatory signaling by the SUMO-deconjugating enzyme SENP6. PLoS Pathog 9, e1003480.
46. Liu, Y., Kieslich, C. A., Morikis, D., and Liao, J. (2014). Engineering pre-SUMO4 as efficient substrate of SENP2. Protein Eng Des Sel 27, 117-126.
47. Lu, H., Liu, B., You, S., Chen, L., Dongmei, Q., Gu, M., Lu, Y., Chen, Y., Zhang, F., and Yu, B. (2013). SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner. Mol Biol Rep 40, 2485-2490.
48. Lu, H., Liu, B., You, S., Xue, Q., Zhang, F., Cheng, J., and Yu, B. (2009). The activity-dependent stimuli increase SUMO modification in SHSY5Y cells. Biochem Biophys Res Commun 390, 872-876.
49. Lomel, H., and Vázquez, M. (2011). Emerging roles of the SUMO pathway in development. Cell Mol Life Sci 68, 4045-4064.
50. Lv, H., Liu, R., Fu, J., Yang, Q., Shi, J., Chen, P., Ji, M., Shi, B., and Hou, P. (2014). Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway. Cell Cycle 13, 2962-2974.
51. Lyst, M. J., and Stancheva, I. (2007). A role for SUMO modification in transcriptional repression and activation. Biochem Soc Trans 35, 1389-1392.
52. Maggi, L. B., Jr., Kuchenruether, D., Dadey, D. Y., Schwope, R. M., Grisendi, S., Townsend, R. R., Pandolfi, P. P., and Weber, J. D. (2008). Nucleophosmin serves as a rate-limiting nuclear export chaperone for the mammalian ribosome. Mol Cell Biol 28, 7050-7065.
53. Meyer, R. E., Kim, S., Obeso, D., Straight, P. D., Winey, M., and Dawson, D. S. (2013). Mps1 and Ipl1/Aurora B act sequentially to correctly orient chromosomes on the meiotic spindle of budding yeast. Science 339, 1071-1074.
54. Mukhopadhyay, D., Arnaoutov, A., and Dasso, M. (2010). The SUMO protease SENP6 is essential for inner kinetochore aassembly. J Cell Biol 8, 681-692.
55. Mukhopadhyay, D., and Dasso, M. (2007). Modification in reverse: The SUMO proteases. Trends Biochem Sci 32, 286-295.
56. Nacerddine, K., Lehembre, F., Bhaumik, M., Artus, J., Cohen-Tannoudji, M., Babinet, C., Pandolfi, P. P., and Dejean, A. (2005). The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell 9, 769-779.
57. Nair, S. S., Nair, B. C., Cortez, V., Chakravarty, D., Metzger, E., Schule, R., Brann, D. W., Tekmal, R. R., and Vadlamudi, R. K. (2010). PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-a target gene activation by regulating lysine demethylase 1 specificity. EMBO Rep 11, 438-444.
58. Nayak, A., Viale-Bouroncle, S., Morsczeck, C., and Muller, S. (2014). The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation. Mol Cell 55, 47-58.
59. Nishida, T., Kaneko, F., Kitagawa, M., and Yasuda, H. (2001). Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation. J Biol Chem 276, 39060-39066.
60. Nishida, T., and Yamada, Y. (2011). The nucleolar SUMOspecific proteaseSMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation. Biochem Biophys Res Commun 406, 285-291.
61. Oh, Y., and Chung, K. C. (2012). Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling. J Biol Chem 287, 17517-17529.
62. Qi, Y., Zuo, Y., Yeh, E. T., and Cheng, J. (2014). An essential role of small ubiquitin-like modifier (SUMO)-specific protease 2 in myostatin expression and myogenesis. J Biol Chem 289, 3288-3293.
63. Quin, J. E., Devlin, J. R., Cameron, D., Hannan, K. M., Pearson, R. B., and Hannan, R. D. (2014). Targeting the nucleolus for cancer intervention. Biochim Biophys Acta 1842, 802-816.
64. Sasaki, M., Kawahara, K., Nishio, M., Mimori, K., Kogo, R., Hamada, K., Itoh, B., Wang, J., Komatsu, Y., and Yang, Y. R. (2011). Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat. Med 17, 944-951.
65. Schulz, S., Chachami, G., Kozaczkiewicz, L., Winter, U., Stankovic-Valentin, N., Haas, P., Hofmann, K., Urlaub, H., Ovaa, H., Wittbrodt, J., Meulmeester, E., and Melchior, F. (2012). Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Rep 13, 930-938.
66. Sharma, P., Yamada, S., Lualdi, M., Dasso, M., and Kuehn, M. R. (2013). Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo. Cell Rep 3, 1640-1650.
67. Sherr, C. J., Bertwistle, D., DEN, B. W., Kuo, M. L., Sugimoto, M., Tago, K., Williams, R. T., Zindy, F., and Roussel, M. F. (2005). p53-dependent and-independent functions of the Arf tumor suppressor. Cold Spring Harb Symp Quant Biol 70, 129-137.
68. Shin, E. J., Shin, H. M., Nam, E., Kim, W. S., Kim, J. H., Oh, B. H., and Yun, Y. (2012). DeSUMOylating isopeptidase: A second class of SUMO protease. EMBO Rep 3, 339-346.
69. Shin, Y. C., Tang, S. J., Chen, J. H., Liao, P. H., and Chang, S. C. (2011). The molecular determinants of NEDD8 specific recognition by human SENP8. PLoS One 6, e27742.
70. Song, J. G., Xie, H. H., Li, N., Wu, K., Qiu, J. G., Shen, D. M., and Huang, C. J. (2015). SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1. Tumour Biol. [Epub ahead of print]; DOI: 10. 1007/s13277-015-3737-z.
71. Sutinen, P., Malinen, M., Heikkinen, S., and Palvimo, J. J. (2014). SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner. Nucleic Acids Res 42, 8310-8319.
72. Thomson, E., Ferreira-Cerca, S., and Hurt, E. (2013). Eukaryotic ribosome biogenesis at a glance. J Cell Sci 126, 4815-4821.
73. Wang, Q., Xia, N., Li, T., Xu, Y., Zou, Y., Zuo, Y., Fan, Q., Bawa-Khalfe, T., Yeh, E. T., and Cheng, J. (2013). SUMOspecific protease 1 promotes prostate cancer progression and metastasis. Oncogene 32, 2493-2498.
74. Wang, W., Budhu, A., Forgues, M., and Wang, X. M. (2005). Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biology 7, 823-830.
75. Wang, W., Yang, P., Pang, J., Zhang, S., Wang, Y., Wang, M. H., Dong, Z., She, J. X., and Wang, C. Y. (2008). Stressdependent SUMO4 sumoylation of its substrate proteins. Biochem Biophys Res Commun 375, 454-459.
76. Wang, Y., Yang, J., Yang, K., Cang, H., Huang, X. Z., Li, H., and Yi, J. (2012). The biphasic redox sensing of SENP3 accounts for the HIF-1 transcriptional activity shift by oxidative stress. Acta Pharmacol Sin 33, 953-963.
77. Wang, Z. B., Ou, X. H., Tong, J. S., Li, S. L., Ouyang, Y. C., Hou, Y., Schatten, H., and Sun, Q. Y. (2010). The SUMO pathway functions in mouse oocyte maturation. Cell Cycle 9, 2640-2646.
78. Welburn, J. P., Vleugel, M., Liu, D., Yates, J. R., Lampson, M. A., Fukagawa, T., and Cheeseman, I. M. (2010). Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface. Mol Cell 38, 383-392.
79. Witty, J., Aguilar-Martinez, E., and Sharrocks, A. D. (2010). SENP1 participates in the dynamic regulation of Elk-1 SUMOylation. Biochem J 428, 247-254.
80. Xirodimas, D. P., Sundqvist, A., Nakamura, A., Shen, L., Botting, C., and Hay, R. T. (2008). Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep 9, 280-286.
81. Yamaguchi, T., Sharma, P., Athanasiou, M., Kumar, A., Yamada, S., and Kuehn, M. R. (2005). Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development. Mol Cell Biol 25, 5171-5182.
82. Yang, X. J., and Chiang, C. M. (2013). Sumoylation in gene regulation, human disease, and therapeutic action. F1000Prime Rep 5, 45.
83. Yeh, E. T. (2009). SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 284, 8223-8227.
84. Yu, T., Huang, C., Xia, X., Liu, X., Gu, J., Xue, S., Yeh, E. T., and Cheng, J. (2012). SUMO-specific protease 1 regulates mitochondrial biogenesis through PGC-1a. J Biol Chem 287, 44464-44470.
85. Yu, Y., Jr., Maggi, L. B., Brady, S. N., Apicelli, A. J., Dai, M. S., Lu, H., and Weberm, J. D. (2006). Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol 26, 3798-3809.
86. Yun, C., Wang, Y., Mukhopadhyay, D., Backlund, P., Kolli, N., Yergey, A., Wilkinson, K. D., and Dasso, M. (2008). Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases. J Cell Biol 183, 589-595.
87. Zemp, I., and Kutay, U. (2007). Nuclear export and cytoplasmic maturation of ribosomal subunits. FEBS Lett 581, 2783-2793.
88. Zeng, H. T., Richani, D., Sutton-McDowall, M. L., Ren, Z., Smitz, J. E., Stokes, Y., Gilchrist, R. B., and Thompson, J. G. (2014). Prematuration with cyclic adenosine modulators alters cumulus cell and oocyte metabolism and enhances developmental competence of in vitro-matured mouse oocytes. Biol Reprod 91, 47.
89. Zhang, H., Saitoh, H., and Matunis, M. J. (2002). Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell Biol 22, 6498-6508.
90. Zhang, H., Smolen, G. A., Palmer, R., Christoforou, A., van den Heuvel, S., and Haber, D. A. (2004). SUMO modification is required for in vivo Hox gene regulation by the Caenorhabditis elegans polycomb group protein SOP-2. Nat Genet 36, 507-511.
91. Zhang, P., Bergamin, E., and Couture, J. F. (2013). The many facets of MLL1 regulation. Biopolymers 99, 136-145.
92. Zunino, R., Braschi, E., Xu, L., and McBride, H. M. (2009). Translocation of SENP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis. J Biol Chem 26, 17783-17795.
93. Zunino, R., Schauss, A., Rippstein, P., Andrade-Navarro, M., and McBride, H. M. (2007). The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J Cell Sci 120, 1178-1188.